Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases

Código QR

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases

Guardado en:

Detalles Bibliográficos
Autor principal:	Lakshmanan Suresh
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/1558b371a87e470998a3c590901d7632
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Vaccinations in rheumatic diseases
por: Martyna Szwejkowska, et al.
Publicado: (2020)

COVID-19 – rheumatic diseases and rheumatologists
por: Maria Maślińska
Publicado: (2021)

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Jasvinder A Singh, et al.
Publicado: (2021)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Athanasios-Dimitrios Bakasis, et al.
Publicado: (2021)

The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis
por: Xuanyu Hao, et al.
Publicado: (2017)

Clinical significance of monitoring hypothyroidism in patients with autoimmune rheumatic disease: a retrospective cohort study
por: Sho Fukui, et al.
Publicado: (2021)

NOVEL METHODS FOR AUTOANTIBODY DETECTION IN LABORATORY DIAGNOSTICS OF AUTOIMMUNE RHEUMATIC DISEASES
por: D. Roggenbuck, et al.
Publicado: (2014)

Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
por: Sotiris C Plastiras, et al.
Publicado: (2021)

PEGylated PLGA Nanoparticle Delivery of Eggmanone for T Cell Modulation: Applications in Rheumatic Autoimmunity
por: Haycook CP, et al.
Publicado: (2020)

Liver involvement in rheumatic diseases
por: Joanna Podgórska, et al.
Publicado: (2020)

Rheumatic Fever & Rheumatic Heart Disease

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19
por: Carlo Perricone, et al.
Publicado: (2020)

Polygenic risk scores and rheumatic diseases
por: Matthew A. Brown, et al.
Publicado: (2021)

Autoimmune Thrombocytopenia in SLE and COVID-19
por: Yeremia Suryo Pratama, et al.
Publicado: (2021)

Association of Parvovirus B19 with Rheumatic Diseases
por: Chi Kit Au, et al.
Publicado: (2021)

Health related quality of life among Rheumatic Fever and Rheumatic Heart Disease patients in India.
por: Jyoti Dixit, et al.
Publicado: (2021)

Health related quality of life among Rheumatic Fever and Rheumatic Heart Disease patients in India
por: Jyoti Dixit, et al.
Publicado: (2021)

The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
por: Reimold AM
Publicado: (2012)

The impact of COVID-19 and healthcare system changes on the well-being of rheumatic patients
por: Aleksandra Opinc, et al.
Publicado: (2021)

Features of heritable disorders of connective tissue in children with acute rheumatic fever and rheumatic heart disease
por: Oksana Boyarchuk
Publicado: (2020)

The macrophages in rheumatic diseases
por: Laria A, et al.
Publicado: (2016)

IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
por: Ivan Caiello, et al.
Publicado: (2014)

Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases
por: Daniel Clemente, et al.
Publicado: (2021)

Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Gian Luca Erre, et al.
Publicado: (2019)

Brief update on coronavirus disease 2019 (COVID-19) diagnostics
por: Lippi Giuseppe
Publicado: (2020)

RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
por: Fatma YILMAZ, et al.
Publicado: (2021)

Clinical manifestations of Whipple’s disease mimicking rheumatic disorders
por: Eugeniusz J. Kucharz, et al.
Publicado: (2021)

Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?
por: Athanasios Sachinidis, et al.
Publicado: (2021)

Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics
por: Gavriilaki Eleni, et al.
Publicado: (2021)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Barbara Ruaro, et al.
Publicado: (2021)

Differential diagnostic value of rheumatic symptoms in patients with Whipple’s disease
por: Gerhard E. Feurle, et al.
Publicado: (2021)

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
por: Cantatore FP, et al.
Publicado: (2017)

International journal of rheumatic diseases

Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19
por: Rahajeng N. Tunjungputri, et al.
Publicado: (2021)

Clinical application of mesenchymal stem cells in rheumatic diseases
por: Yajing Wang, et al.
Publicado: (2021)

Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator
por: Meng-Lei Zhu, et al.
Publicado: (2016)

Gut Microbiota–Medication Interaction in Rheumatic Diseases
por: Lingshu Zhang, et al.
Publicado: (2021)

COVID-19 Vaccination Behavior of People Living with HIV: The Mediating Role of Perceived Risk and Vaccination Intention
por: Li Qi, et al.
Publicado: (2021)

Romatizma/Rheumatism

COVID-19: an updated review
por: F. A. Isihak, et al.
Publicado: (2020)